Find Hospitals in United States (US)

Hospitals in United States (US)
Location: United States

Comments

Post a Comment

Popular posts from this blog

NAC vs NAD vs NR vs NMN vs Niacin: What Are the Differences?

Image
By the One Day MD Editorial Team  |  Originally published September 2020  |  Last updated and medically fact-checked: August 2026 NAD, NAD+, NADH, NR, NMN, niacin, niacinamide, and NAC — these overlapping names cause constant confusion, and understandably so. Some are simply different names for the same molecule. Others are metabolic precursors that your body converts, step by step, into NAD+. One of them, NAC, isn't related to NAD+ metabolism at all. This guide breaks down what each compound actually does, how the human evidence stacks up as of 2026, and where the real safety trade-offs lie — including the January 2026 head-to-head human trial that finally pitted NR against NMN directly, and the FDA's 2025 reversal on NMN's legal status. Quick Answer NAD+ is the coenzyme your cells actually need for energy production and DNA repair, and it can't be taken as an oral supplement because it's too large a molecule to survive digestion intact. NR, NMN, n...
Read more

Ivermectin for Parkinson’s and Dementia: Analyzing the Neuroprotective Molecular Evidence and Clinical Case Reports (2026)

Image
Scientific Review & Regulatory Audit by the Clinical Editorial Team The therapeutic paradigm for progressive neurodegenerative disorders like Parkinson’s disease (PD) and various forms of dementia faces a critical bottleneck. Standard pharmacology, primarily anchored by levodopa (L-DOPA) for Parkinson’s and acetylcholinesterase inhibitors for dementia, remains strictly symptomatic. These options frequently suffer from diminishing efficacy and significant side-effect profiles like L-DOPA-induced dyskinesia over long-term use. Consequently, the pharmaceutical community has focused heavily on drug repurposing—identifying established, safety-vetted compounds capable of crossing pathways to modify disease progression. An unexpected frontline candidate emerging in this space is ivermectin. Traditionally classified as a broad-spectrum antiparasitic agent, a surge of preclinical studies between 2020 and 2024 has unveiled its complex, multi-targeted pharmacodynamics within the mam...
Read more

Best Gynecologists & Obstetricians (OBGYN) in Johor: Directory & Guide (2026)

Image
Gynaecology or gynecology is the medical practice dealing with the health of the female reproductive systems (vagina, uterus and ovaries), breasts and pregnancy related management. Literally, outside medicine, it means "the science of women". Almost all modern gynaecologists are also obstetricians and therefore the term obstetricians & gynecologists or O&G or OBGYN in short. In many areas, the specialties of gynaecology and obstetrics overlap. Finding a trusted medical specialist is one of the most personal and critical healthcare decisions a woman can make. Whether you are navigating your first pregnancy, seeking treatment for reproductive health concerns, or exploring fertility options like IVF, choosing the right doctor matters deeply. In this completely updated guide, we highlight the leading obstetricians and gynecologists (O&G or OBGYN) in Johor . From major government referral institutions to premiu...
Read more

SELECT, STEP, SURPASS, SURMOUNT & FLOW: What the Landmark Semaglutide and Tirzepatide Trials Actually Prove (2026)

Image
By Dr. Frank Yap, MD  |  Medically reviewed by One Day MD Review Team  |  Last updated: August 2026 Quick Answer SELECT showed that semaglutide 2.4 mg cuts major cardiovascular events by 20% in people with overweight/obesity and existing heart disease who do not have diabetes. The STEP program (STEP 1–5, STEP 8, and the newer STEP UP trials) established semaglutide's weight-loss profile, with losses ranging from roughly 10% to over 20% of body weight depending on dose, population, and duration. The SURPASS program showed that tirzepatide — a dual GIP/GLP-1 agonist — produces larger HbA1c and weight reductions than semaglutide in type 2 diabetes, and the newly published SURPASS-CVOT (December 2025) confirmed tirzepatide is at least as cardioprotective as dulaglutide. FLOW showed semaglutide cuts major kidney disease events by 24% in people with type 2 diabetes and chronic kidney disease, which led the FDA to approve a dedicated kidney-protection indic...
Read more

Top Peptide Protocols 2026: Best Stacks for Fat Loss, Recovery, Anti-Aging & Longevity

Image
By Dr. Frank Yap, MD  |  Originally published April 2026  |  Fully updated August 26, 2026 for the FDA's July 2026 compounding committee vote Quick Answer As of August 2026, GLP-1 receptor agonists (semaglutide, tirzepatide) remain the only peptides in this guide with full FDA approval. On July 23–24, 2026, an FDA advisory committee (PCAC) recommended adding BPC-157, KPV, TB-500, MOTS-c, Semax, and Epitalon to the list of substances compounding pharmacies may use — but that vote is non-binding, and none of the six is lawful to compound yet; formal rulemaking is expected to take 12–24 months. Separately, AOD-9604 failed its pivotal human obesity trial back in 2007. The best human evidence among the non-GLP-1 peptides here belongs to topical GHK-Cu (skin) and Selank (anxiety); the weakest belongs to BPC-157 and TB-500 (mostly animal data). Any protocol should run through a licensed physician — not a gray-market vendor. Medical & regu...
Read more

How Many Years Can a Healthy Lifestyle Add to Your Life? The Evidence on Diet, Exercise, Supplements & Anti-Aging Drugs (2026)

Image
Short answer: A healthy lifestyle may add years to life—and potentially a decade or more in some populations—but there is no scientifically valid number that applies to everyone. The strongest evidence suggests that the biggest gains come from a combination of not smoking, regular physical activity, a high-quality diet, maintaining a healthy body weight, and controlling major cardiovascular and metabolic risk factors . One influential U.S. analysis estimated that people who followed five low-risk lifestyle factors at age 50 had a projected life expectancy about 14 years longer for women and 12 years longer for men than people following none of those factors. However, this was a prospective observational analysis combined with life-table modelling—not a randomized trial proving that each person will live exactly 12–14 years longer. That distinction matters. It is tempting to interpret longevity studies as if they were a prescription for an extra number of years: exercise gi...
Read more

Digital Patient Monitoring and Wearables: Transforming Healthcare in 2026

Image
Digital patient monitoring and wearables have moved far beyond fitness trackers. In 2026, these technologies form the backbone of remote patient monitoring (RPM), enabling continuous, real-time health data collection outside hospitals. From detecting atrial fibrillation on a smartwatch to predicting heart failure decompensation with clinical-grade patches, wearables are shifting healthcare from reactive treatment to proactive, personalized care. This comprehensive guide covers everything you need to know about digital patient monitoring and wearables — market growth, key technologies, clinical benefits, leading devices, challenges, and what the future holds. What Is Digital Patient Monitoring and Wearables? Digital patient monitoring refers to the continuous or frequent collection of physiological data using connected devices that transmit information to healthcare providers or patients themselves. Wearables are the primary tools enabling this: smartwatches, smart rings, adh...
Read more

18 Best Supplements to Reduce Cytokine Storm: Advanced Guide

Image
As of May 2024, there are more than 4,000 early treatment studies  that have been published and shared with the whole world. New ones are being added every day.  This is a review of the literature, covering multiple observational studies, randomized controlled trials and references related to natural supplements and cytokine storm with more than 300 studies and references. We know that while a large percentage of the population only experiences mild to moderate symptoms of COVID-19 and won’t require hospitalization, others experience severe symptoms and complications, require hospitalization, or may even die.  It appears one of the differences between those who have a mild illness and severe illness is related to the body's ability to reduce the hyperimmune response that leads to a cytokine storm and the hyper-coagulability (tendency for blood clots) that often accompanies it. The cytokine storm may be one possible way to ex...
Read more

Molecular Hydrogen Therapy: Evidence Review and the Science Behind (2026)

A comprehensive, peer-reviewed synthesis of preclinical and clinical evidence for H₂ therapy across 20 disease categories — 2026 Update Published: June 2026 Last Reviewed: June 2026   2026 Update References: 160+ citations Category: Integrative Medicine | Antioxidant Therapy Reading Time: ~18 min Peer-Reviewed Format Abstract Molecular hydrogen (H₂) has emerged over the past two decades as a uniquely versatile therapeutic agent, distinguished by its ability to selectively scavenge cytotoxic reactive oxygen species (ROS) while crossing all biological barriers, including the blood-brain barrier. Since the landmark 2007 Nature Medicine publication, more than 5,000 papers and over 100 registered clinical trials have examined H₂ across conditions spanning neurodegeneration, cancer, cardiovascular disease, metabolic syndrome, inflammatory disorders, and respiratory illness. This updated review synth...
Read more

9 Best Berberine Supplements (2026 Review): Evidence, Dosage & New EU Safety Data

Image
By Dr Frank Yap, MD | Medically reviewed by the One Day MD Editorial Team | Last updated: August 2026 | Original publication: March 2023 Quick Answer A 2024–2025 meta-analysis of 50 RCTs (4,150 patients) confirms berberine modestly but reliably lowers fasting glucose, HbA1c, LDL cholesterol and inflammatory markers in type 2 diabetes and metabolic syndrome — solid, Tier 1a evidence. It is not "nature's Ozempic." Semaglutide produces roughly 10–15%+ body-weight loss in trials; berberine averages only about 2–4 lb a month. The mechanisms and effect sizes aren't comparable. Typical dosing is 500 mg, 2–3x daily with meals (1,000–1,500 mg/day). Bioavailability — not the milligram number on the label — is the biggest real difference between brands. New in 2026: A draft EU/UK scientific opinion (EFSA/COT, March 2026) flagged in-vitro genotoxicity signals, confirmed the CYP3A4 drug-interaction risk, and stated that regulators cannot yet establish a formal "...
Read more